Literature DB >> 1520571

The causes and clinical significance of exercise-induced silent myocardial ischemia evaluated by ischemic range and intensity with exercise Tl-201 myocardial SPECT.

N Moriai1, K Nakai, K Hiramori.   

Abstract

We investigated the causes and long-term prognosis of exercise-induced silent myocardial ischemia (SMI) by means of exercise Tl-201 myocardial SPECT (Ex-SPECT) in 97 patients with effort angina or old myocardial infarction (OMI). These patients were proven to have significant stenosis by coronary angiography. The subjects were divided into three groups based on the presence or absence of Tl-201 redistribution or angina during exercise testing. Group one consisted of 34 patients who had redistribution on Ex-SPECT and angina during exercise testing: the painful myocardial ischemia (PMI) group. The second group consisted of 38 patients who had redistribution on Ex-SPECT, but no angina during exercise testing: the SMI group. The third group consisted of 25 patients who had no redistribution: the RD (-) group. The ischemic range and intensity were quantified by the defect volume ratio (DVR) and defect severity index (DSI), respectively. Comparison of the DVR and DSI values for the PMI and SMI groups revealed that the DVR and DSI values for the SMI group were lower than those of the PMI group. Also the prognosis of the SMI group tended to be worse than that of the RD (-) group. Thus, we concluded that the SMI and PMI group should receive identical treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520571     DOI: 10.1007/bf03164639

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  11 in total

1.  [A case of myocardial infarction with ventricular tachycardia, which had discrepancy of defect size between 123I-MIBG and 201TlCl myocardial imaging].

Authors:  T Nishimura; T Kurita; T Ohe; K Hayashida; T Uehara; I Mitani; H Oka; M Hayashi
Journal:  Kaku Igaku       Date:  1989-03

2.  [Evaluation of ischemic myocardium with regional time-activity curve of Tl-201].

Authors:  T Katsuki; T Iino; N Toyosaki; T Natsume; T Yaginuma; S Hosoda; Y Kawamura; I Misawa; M Furuse
Journal:  Kaku Igaku       Date:  1987-10

3.  Recognition, pathogenesis, and management options in silent coronary artery disease: introduction.

Authors:  P F Cohn; W B Kannel
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

4.  Search for a cardiac nociceptor: stimulation by bradykinin of sympathetic afferent nerve endings in the heart of the cat.

Authors:  D G Baker; H M Coleridge; J C Coleridge; T Nerdrum
Journal:  J Physiol       Date:  1980-09       Impact factor: 5.182

5.  Plasma beta-endorphin levels in silent myocardial ischemia induced by exercise.

Authors:  G V Heller; C E Garber; M J Connolly; C F Allen-Rowlands; S F Siconolfi; D S Gann; R A Carleton
Journal:  Am J Cardiol       Date:  1987-04-01       Impact factor: 2.778

6.  Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.

Authors:  J C Sisson; B Shapiro; L Meyers; S Mallette; T J Mangner; D M Wieland; J V Glowniak; P Sherman; W H Beierwaltes
Journal:  J Nucl Med       Date:  1987-10       Impact factor: 10.057

Review 7.  Silent myocardial ischemia: II. Prognosis and implications for the clinical assessment of patients with coronary artery disease.

Authors:  A Rozanski; D S Berman
Journal:  Am Heart J       Date:  1987-09       Impact factor: 4.749

8.  Quantification of rotational thallium-201 myocardial tomography.

Authors:  E V Garcia; K Van Train; J Maddahi; F Prigent; J Friedman; J Areeda; A Waxman; D S Berman
Journal:  J Nucl Med       Date:  1985-01       Impact factor: 10.057

9.  Clinical and prognostic significance of silent myocardial ischemia in survivors after acute myocardial infarction.

Authors:  K Fukami; K Haze; K Ueshima; F Kasagi; K Hiramori
Journal:  Jpn Circ J       Date:  1989-11

10.  Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina.

Authors:  S O Gottlieb; M L Weisfeldt; P Ouyang; E D Mellits; G Gerstenblith
Journal:  N Engl J Med       Date:  1986-05-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.